<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-05T22:08:17Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/16738" metadataPrefix="etdms">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/16738</identifier><datestamp>2021-06-23T09:52:07Z</datestamp><setSpec>com_10324_1134</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1213</setSpec></header><metadata><thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.0/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>Protective effects of epoxypukalide on pancreatic b-cells and glucose metabolism in STZ-induced diabetic mice</title>
<creator>López Acosta, José Francisco</creator>
<creator>Villa Pérez, Pablo</creator>
<creator>Fernández Díaz, Cristina María</creator>
<creator>Luis Román, Daniel Antonio de</creator>
<creator>Díaz Marrero, Ana R.</creator>
<creator>Cueto, Mercedes</creator>
<creator>Perdomo Hernández, Germán</creator>
<creator>Cózar Castellano, Irene</creator>
<subject>Diabetes - Tratamiento</subject>
<description>Producción Científica</description>
<description>Diabetes is a consequence of a decrease on functional β-cell mass. We have recently demonstrated that epoxypukalide (Epoxy) is a natural compound with beneficial effects on primary cultures of rat islets. In this study, we extend our previous investigations to test the hypothesis that Epoxy protects β-cells and improves glucose metabolism in STZ-induced diabetic mice. We used 3-months old male mice that were treated with Epoxy at 200 μg/kg body weight. Glucose intolerance was induced by multiple intraperitoneal low-doses of streptozotocin (STZ) on 5 consecutive days. Glucose homeostasis was evaluated measuring plasma insulin levels and glucose tolerance. Histomorphometry was used to quantify the number of pancreatic β-cells per islet. β-cell proliferation was assessed by BrdU incorporation, and apoptosis by TUNEL staining. Epoxy treatment significantly improved glucose tolerance and plasma insulin levels. These metabolic changes were associated with increased β-cell numbers, as a result of a two-fold increase in β-cell proliferation and a 50% decrease in β-cell death. Our results demonstrate that Epoxy improves whole-body glucose homeostasis by preventing pancreatic β-cell death due to STZ-induced toxicity in STZ-treated mice</description>
<date>2016-04-11</date>
<date>2016-04-11</date>
<date>2015</date>
<type>info:eu-repo/semantics/article</type>
<identifier>Islets,(2015);7(2):e1078053</identifier>
<identifier>1938-2014</identifier>
<identifier>http://uvadoc.uva.es/handle/10324/16738</identifier>
<identifier>10.1080/19382014.2015.1078053</identifier>
<identifier>e1078053</identifier>
<identifier>2</identifier>
<identifier>Islets</identifier>
<identifier>7</identifier>
<language>eng</language>
<rights>info:eu-repo/semantics/openAccess</rights>
<rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</rights>
<rights>Attribution-NonCommercial-NoDerivatives 4.0 International</rights>
<publisher>Taylor &amp; Francis</publisher>
</thesis></metadata></record></GetRecord></OAI-PMH>